pGEX-optimized E6AP F727D
(Plasmid
#165101)
-
Purposeecoli optimized expression of a GST fusion of Human E6AP F727D
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 165101 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGEX4T1
-
Backbone manufacturerGE Healthcare
- Backbone size w/o insert (bp) 4900
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameE6AP F727D
-
Alt nameUBE3A
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2620
-
Mutationcodon optimized for E. coli expression
-
Entrez GeneUBE3A (a.k.a. ANCR, AS, E6-AP, EPVE6AP, HPVE6A, PIX1)
-
Tag
/ Fusion Protein
- GST from plasmid. (N terminal on insert)
Cloning Information
- Cloning method Ligation Independent Cloning
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Amino acid numbering is based on Isoform 1 though this clone is isoform 3. The sequence is 5'-SPLKYLFRPEE-3' where F has been mutated to D. Best yields for protein purification were found in BL21 (DE) cells using an overnight induction at 16 degrees C.
5' Cloning Site: EcoRI (not destroyed), 3' Cloning Site: XhoI (not destroyed).
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGEX-optimized E6AP F727D was a gift from Arthur Haas (Addgene plasmid # 165101 ; http://n2t.net/addgene:165101 ; RRID:Addgene_165101) -
For your References section:
The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer. Ronchi VP, Klein JM, Edwards DJ, Haas AL. J Biol Chem. 2014 Jan 10;289(2):1033-48. doi: 10.1074/jbc.M113.517805. Epub 2013 Nov 22. 10.1074/jbc.M113.517805 PubMed 24273172